ACCULAB, LLC
NPI 1710353974
Clinical Medical Laboratory in Bowling Green, KY
NPI Status: Active since August 11, 2015
Contact Information
1043 PEDIGO WAY
SUITE 15
BOWLING GREEN, KY
ZIP 42103
Phone: (615) 268-1066
- Organization
- Clinical Medical Laboratory
About ACCULAB, LLC
This page provides the complete NPI Profile along with additional information for Acculab, Llc, a provider established in Bowling Green, Kentucky operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1710353974 assigned on August 2015. The practitioner's primary taxonomy code is 291U00000X with license number 18D2098942 (KY). The provider is registered as an organization and their NPI record was last updated 11 years ago. The authorized official of this NPI record is Erin Woodward (Senior Managing Director)
- NPI
- 1710353974
- Provider Name
- ACCULAB, LLC
- Entity Type
- Organization
- Location Address
- 1043 PEDIGO WAY SUITE 15 BOWLING GREEN, KY 42103
- Location Phone
- (615) 268-1066
- Mailing Address
- 1043 PEDIGO WAY SUITE 15 BOWLING GREEN, KY 42103
- Mailing Phone
- (615) 268-1066
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 08-11-2015
- Last Update Date
- 08-11-2015
- Code Navigator
Establishments like Acculab, Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- License No.
- 18D2098942
- License State
- KY
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen
Detection of mycoplasma genitalium by dna or rna probe
Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique
Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique
Detection test by nucleic acid for organism, amplified probe technique
Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
Testing for presence of drug, by chemistry analyzers
This service involves the testing for COVID-19 using advanced technologies that can process multiple samples at once. It identifies different types or subtypes of the virus, including SARS-CoV-2/2019-nCoV. This test is non-CDC but adheres to the guidelines outlined in CMS-2020-01-R.
This service was performed 42 times for 32 patientsThis is a lab test that detects the presence of COVID-19 in your body. It uses a technique to amplify the virus's genetic material, either DNA or RNA, making it easier to identify. A positive result indicates an active infection.
This service was performed 39 times for 29 patientsThis procedure involves the use of special probes to identify the presence of a specific bacteria, Mycoplasma Genitalium, in your body. These probes detect the bacteria's unique DNA or RNA, helping to confirm if you have an infection.
This service was performed 52 times for 49 patientsA detection test by nucleic acid for chlamydia trachomatis, amplified probe technique, is a test that identifies the presence of a specific bacteria in the body. This bacteria can cause various health issues. The technique amplifies the sample to improve accuracy.
This service was performed 91 times for 77 patientsThis is a lab test that checks for the presence of a specific bacteria called Neisseria gonorrhoeae in your body. It uses a technique called amplified probe, which makes many copies of the bacteria's genetic material (nucleic acid) to help detect it more easily.
This service was performed 91 times for 77 patientsA nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.
This service was performed 279 times for 65 patientsThis is a test to identify a common microscopic organism that can cause discomfort. The technique involves using a special probe to amplify the organism's genetic material, making it easier to detect. It's a simple, safe, and accurate procedure.
This service was performed 71 times for 64 patientsA definitive drug test is a detailed examination that can identify specific drugs in your system, even closely related ones. Techniques like GC/MS and LC/MS are used for high precision. This helps ensure accurate results for your safety and health.
This service was performed 110 times for 36 patientsA definitive drug test is a detailed analysis used to identify specific drugs in your system. It uses advanced techniques, such as gc/ms and lc/ms, to detect and distinguish between different drugs, even those with similar structures.
This service was performed 130 times for 98 patientsA definitive drug test identifies specific drugs in your system. Advanced methods like GC/MS (Gas Chromatography/Mass Spectrometry) and LC/MS (Liquid Chromatography/Mass Spectrometry) are used. These can distinguish between similar drugs, providing precise results.
This service was performed 1,146 times for 374 patientsA definitive drug test identifies specific drugs in your system. It uses advanced methods like gc/ms and lc/ms, which can distinguish between different types of drugs but not necessarily their 3D forms. This test offers detailed results to support your healthcare decisions.
This service was performed 3,004 times for 1,032 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 30 times for 23 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 47 times for 37 patientsChemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.
This service was performed 1,721 times for 574 patientsReviews for ACCULAB, LLC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1710353974, we treat the final digit (4) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 66. The final step is to find the difference between that total and the next multiple of ten (70 - 66 = 4).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 66 is 70. The difference is the calculated check digit.
Other Providers at the Same Location
The following 4 providers are registered at the same or a nearby location.
BOWLING GREEN, KY 42103
BOWLING GREEN, KY 42103
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1710353974, enumerated as an "organization" on August 11, 2015.
The provider is located at 1043 PEDIGO WAY SUITE 15 BOWLING GREEN, KY 42103 and the phone number is (615) 268-1066.
Clinical Medical Laboratory with taxonomy code 291U00000X.